MTHFR and pachyonychia congenita: A functional study indicated that MTHFR rs1801133 G>A polymorphism was a protective factor of prostate cancer (PC) susceptibility by elevating homocysteine level, promoting cell apoptosis, and inhibiting proliferation of PC cells [21].